2/20/2024
ELEM Biotech
Product

Introducing Harbor™ Targeted Integration Technology

ELEM Biotech launches revolutionary Harbor™ technology platform enabling rapid, efficient targeted gene integration for stable cell line development.

We're excited to announce the launch of Harbor™, our proprietary targeted integration technology that dramatically accelerates stable cell line generation. This breakthrough platform reduces timeline from months to just three weeks while maintaining high efficiency and reproducibility.

The Challenge of Stable Cell Line Development

Traditional stable cell line generation faces several limitations:

  • Time-consuming: Random integration approaches require 2-3 months of selection and screening
  • Variable expression: Random genomic insertion leads to unpredictable expression levels
  • Low efficiency: Multiple rounds of screening needed to identify suitable clones
  • Silencing risk: Transgenes may be silenced over time due to epigenetic effects

Harbor™ Technology: A Game-Changer

Our Harbor™ system combines:

Proprietary Harbor Cell Lines: Pre-engineered with optimized genomic safe harbor sites that ensure:

  • Consistent, high-level transgene expression
  • Stable expression over extended passages
  • Minimal impact on endogenous gene function
  • Compatibility with multiple cell types (HEK293, CHO, Jurkat, and more)

pCargo Vector System: Streamlined cloning vectors featuring:

  • Flexible multiple cloning sites for easy gene insertion
  • Selection markers for efficient clone isolation
  • Optimized regulatory elements for robust expression
  • Compatibility with standard molecular biology workflows

Validated Integration Protocol: Optimized procedures ensuring:

  • 80% integration efficiency

  • Single-copy integration for most applications
  • Rapid selection (7-10 days)
  • Complete characterization and validation

Key Applications

Harbor™ technology is ideal for:

  • Recombinant protein production: Generate stable producer cell lines for antibodies, enzymes, or therapeutic proteins
  • Reporter cell lines: Create sensitive biosensors for drug screening or pathway analysis
  • Overexpression studies: Stably express genes of interest for functional characterization
  • CRISPR applications: Integrate Cas9 or other genome editing components for stable expression

Performance Metrics

In validation studies, Harbor™ demonstrated:

  • 3-week turnaround from transfection to validated clone
  • 85% average integration efficiency
  • <5% variation in expression levels across clones
  • Stable expression maintained for >50 passages

Pricing and Availability

Harbor™ products are now available for order:

  • Harbor™ Cell Lines: Starting at $2,500
  • pCargo Vectors: Starting at $500
  • Custom Integration Services: Contact for quote

Special introductory pricing available for academic institutions and first-time customers.

Conclusion

Harbor™ technology represents a significant advancement in stable cell line generation, offering speed, efficiency, and reliability that traditional methods cannot match. Contact our team today to learn how Harbor™ can transform your cell line development workflow.

Harbor TechnologyStable Cell LinesGene Knock-in
ELEM Biotech - 粒曼生物

Professional high-throughput gene editing solutions provider, dedicated to advancing drug discovery and fundamental research innovation.

Contact

Follow Us

© 2026 ELEM Biotech. All rights reserved.